Literature DB >> 2563669

Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 249 patients in Sweden from 1959 through 1981.

U Bergholm1, H O Adami, R Bergström, H Johansson, G Lundell, M Telenius-Berg, G Akerström.   

Abstract

All patients with medullary thyroid carcinoma (MTC) diagnosed in Sweden during 1959 through 1981 were recruited for study from the Swedish Cancer Registry. Among a total of 249 patients, 66 were diagnosed in 1959 through 1969 and 183 from 1970 through 1981. Apparently sporadic MTC was present in 186 patients, and familial MTC in 63. Twenty-seven patients with familial MTC were diagnosed from clinical symptoms and 36 by screening. In both the sporadic group and the symptomatic familial group, approximately 80% of the patients had palpable thyroid tumors. Lymph node metastases were present in 44% of the sporadic group and in 37% of the group with symptomatic familial MTC, and distant metastases in approximately 20% of the patients in each of these groups. The patients detected by screening differed significantly from the two groups of symptomatic cases by having a lower frequency of palpable thyroid lesions (50%), smaller tumors, and lower frequencies of cervical lymph node metastases (14%) and distant metastases (0%). Multivariate analyses revealed no significant differences between sporadic cases and symptomatic familial cases regarding tumor size or stage. Large tumors (greater than 3 cm) were more frequently accompanied by palpable cervical lymph nodes and were associated with an approximately four times higher risk of distant metastases than tumors smaller than 1 cm. Women had significantly smaller tumors and a more favorable stage distribution than age-related men.

Entities:  

Mesh:

Year:  1989        PMID: 2563669     DOI: 10.1002/1097-0142(19890315)63:6<1196::aid-cncr2820630626>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.

Authors:  Isabel Peixoto Callejo; José Américo Brito; Carlos Manuel Zagalo; Jorge Rosa Santos
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

2.  Fatal sporadic medullary carcinoma of the thyroid.

Authors:  H Ruben Harach; Ulla Bergholm
Journal:  Endocr Pathol       Date:  1993-03       Impact factor: 3.943

3.  Medullary carcinoma of the thyroid with axillary metastasis: a case report.

Authors:  Murat Ozdemir; Ozer Makay; Ilgin Simsir; Yeşim Ertan; Gokhan Icoz; Füsun Saygili; Mahir Akyildiz
Journal:  Int Surg       Date:  2015-03

Review 4.  Thyroid cancer: a review of treatment and follow-up.

Authors:  L Vini; C Harmer; V R McCready
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

5.  Genetic analysis of 24 French families with multiple endocrine neoplasia type 2A.

Authors:  S A Narod; M F Lavoué; K Morgan; C Calmettes; H Sobol; P J Goodfellow; G M Lenoir
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

6.  Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register.

Authors:  F Raue; J Kotzerke; D Reinwein; S Schröder; H D Röher; H Deckart; R Höfer; M Ritter; F Seif; H Buhr
Journal:  Clin Investig       Date:  1993-01

7.  Increased incidence of medullary carcinoma of the thyroid in rural regions in Greece.

Authors:  M Alevizaki; P Papapetrou; P Georgouli; C C Alevizaki; H Papadodima; A Souvatzoglou; D Koutras
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

8.  The Pathology of Medullary Carcinoma of the Thyroid: Review of the Literature and Personal Experience on 62 Cases.

Authors:  Mauro Papotti; Daniela Sambataro; Carla Pecchioni; Gianni Bussolati
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

Review 9.  Medullary thyroid carcinoma: management of lymph node metastases.

Authors:  Frank Jay Quayle; Jeffrey F Moley
Journal:  Curr Treat Options Oncol       Date:  2005-07

10.  Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.

Authors:  J Bojunga; C Dragan; P M Schumm-Draeger; K H Usadel; K Kusterer
Journal:  Br J Cancer       Date:  2001-11-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.